Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptorelin 6‑month depot in Chinese children with central precocious puberty
CTR20211024Phase 3Completed
- Sponsor
- Ipsen
- Start
- May 2021
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of triptorelin in central precocious puberty (CPP), sponsored by Ipsen. Started May 2021; status: completed.
02
Drugs
triptorelin
03
Conditions
central precocious puberty (CPP)
Beyond the preview
Go deeper on CTR20211024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211024.